FDA OKs Liraglutide for Use in Youth With Type 2 Diabetes FDA OKs Liraglutide for Use in Youth With Type 2 Diabetes

Liraglutide is the first noninsulin agent approved to treat pediatric type 2 diabetes in nearly 20 years; approval comes at a time when doctors are increasingly concerned about type 2 diabetes in kids.FDA Approvals
Source: Medscape Pediatrics Headlines - Category: Pediatrics Tags: Diabetes & Endocrinology News Alert Source Type: news